E-ISSN 2636-834X
 
2023, Vol: 13, Issue: 1
13/1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

COPYRIGHT FORM

Case Report 


Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report

Cilem Bilginer.

Abstract
Angioedema is a rare but life-threatening condition characterized by swelling in subcutaneous tissues and mucosa. Paliperidone is an effective treatment option for treatment-resistant patients with depression. While the most common adverse effect caused by medication is headaches, it is also less likely to observe edema or anaphylactic reaction. In this case report, an adolescent diagnosed with major depression and suffered from angioedema following oral paliperidone augmentation during the treatment was presented. Edema regressed spontaneously about 24-30 hours following the last drug intake. No significant laboratory finding that could explain this condition was found. The patient no longer suffered from a similar problem following discontinuation of paliperidone. This case suggests that the clinician should be alerted against possible allergic reactions by reason of oral usage of paliperidone in adolescents and further studies are needed to explore the underlying mechanisms of allergic responses for these patients.

Key words: paliperidone, risperidone, angioedema, adolescent


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Cilem Bilginer
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS. 2017; 7(2): 128-30. doi:10.5455/jmood.20170404040638

Web Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. https://www.pbsciences.org/?mno=258736 [Access: March 28, 2023]. doi:10.5455/jmood.20170404040638

AMA (American Medical Association) Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS. 2017; 7(2): 128-30. doi:10.5455/jmood.20170404040638


Vancouver/ICMJE Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS. (2017), [cited March 28, 2023]; 7(2): 128-30. doi:10.5455/jmood.20170404040638


Harvard Style

Cilem Bilginer (2017) Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS, 7 (2), 128-30. doi:10.5455/jmood.20170404040638


Turabian Style

Cilem Bilginer. 2017. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. Psychiatry and Behavioral Sciences, 7 (2), 128-30. doi:10.5455/jmood.20170404040638


Chicago Style

Cilem Bilginer. "Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report." Psychiatry and Behavioral Sciences 7 (2017), 128-30. doi:10.5455/jmood.20170404040638


MLA (The Modern Language Association) Style

Cilem Bilginer. "Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report." Psychiatry and Behavioral Sciences 7.2 (2017), 128-30. Print. doi:10.5455/jmood.20170404040638


APA (American Psychological Association) Style

Cilem Bilginer (2017) Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. Psychiatry and Behavioral Sciences, 7 (2), 128-30. doi:10.5455/jmood.20170404040638


Author LoginReviewer Login
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Psychiatry and Behavioral Sciences are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright © 2023 Psychiatry and Behavioral Sciences All Rights Reserved. Subject to change without notice from or liability to Psychiatry and Behavioral Sciences.
For best results, please use Internet Explorer or Google Chrome

Contact Information